Related references
Note: Only part of the references are listed.Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents
Jia-Nian Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Sorafenib in the treatment of thyroid cancer
Silvia Martina Ferrari et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Linifanib: current status and future potential in cancer therapy
Caterina Aversa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Tivozanib: Status of Development
Muhammad Omer Jamil et al.
CURRENT ONCOLOGY REPORTS (2015)
Design, synthesis and biological evaluation of novel thieno[3,2-d] pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents
Zijian Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors
Dazhi Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
4-Aminoquinazoline Analogs: A Novel Class of Anticancer Agents
Kalpana Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics
Do-Hee Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents
Nan Jiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Sorafenib A Review of its Use in Advanced Hepatocellular Carcinoma
Gillian M. Keating et al.
DRUGS (2009)
Enantioselective Synthesis of Janus Kinase Inhibitor INCB018424 via an Organocatalytic Aza-Michael Reaction
Qiyan Lin et al.
ORGANIC LETTERS (2009)
Sorafenib for the treatment of advanced renal cell carcinoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors:: Synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N′-{4-[4-quinolyloxy)phenyl}ureas
K Kubo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Share Paper
